NHS England Low Priority Treatment - omega-3 fatty acid compounds
Metadata
- Coding system
- Pseudo BNF
- Coding system release
- unknown
- Organisation
- OpenPrescribing
- Codelist ID
- openprescribing/nhs-england-low-priority-treatment-omega-3-fatty-acid-compounds
- Version ID
- 76187a14
- Number of codes included
- 13
About
Description
Used by the following [OpenPrescribing](https://openprescribing.net) measures:
* [NHS England Low Priority Treatment - omega-3 fatty acid compounds](https://openprescribing.net/measure/lpomega3/)
References
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
| code | term |
|---|---|
| 0212000ABAAAAAA | Eicosapentaenoic acid 460mg/Docosahexaenoic acid 380mg caps |
| 0212000ABBBAAAA | Omacor capsules |
| 0212000ABBCAAAA | Teromeg 1000mg capsules |
| 0212000ABBDAAAA | Prestylon 1g capsules |
| 0212000ABBEAAAA | Omega 3-acid-ethyl esters 1000mg capsules |
| 0212000ABBFAAAA | Nebbaro 1000mg capsules |
| 0212000ABBGAAAA | Omega 3 1000mg capsules |
| 0212000ABBHAAAA | Dualtis 1000mg capsules |
| 0212000ABBIAAAA | G & G Omega 3 1000mg softgels capsules |
| 0212000V0AAAAAA | Eicosapent acid 170mg/Docosahexaenoic acid 115mg/g oral liq |
| 0212000V0AAABAB | Eicosapentaenoic acid 170mg/Docosahexaenoic acid 115mg caps |
| 0212000V0BBAAAA | MaxEPA liquid |
| 0212000V0BBABAB | MaxEPA 1g capsules |